News and Reports
-
Anthera Pharmaceuticals completes $19 million financing
13 August 2008Download -
ESBATech raises additional CHF 23M (USD 22M), extending Series B Venture Financing
7 August 2008Download -
Onyx' Nexavar approved for liver cancer in China
28 July 2008Download -
PTC Therapeutics closes significant cooperation agreement with Genzyme, receives $ 100 million upfront payment
17 July 2008Download -
FDA grants conditional approval to Interventional Spine's PercuDyn system IDE application
1 July 2008Download -
Basilea's Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
30 June 2008Download -
Ipsen to acquire Tercica
4 June 2008Download -
PharmaSwiss raises EUR 35 million from private equity fund
20 May 2008Download -
Onyx' Nexavar significantly improves overall survival by 47% in Asia-Pacific liver cancer study
16 May 2008Download -
Paratek Pharmaceuticals completes $40 Million private placement to finance clinical programs including oral anti-MRSA antibiotics
16 April 2008Download -
Newron reports positive Phase II results for ralfinamide in peripheral neuropathic pain patients
16 April 2008Download -
BRAHMS AG: receives FDA clearance to market automated procalcitonin (PCT) test
7 April 2008Download -
ESBATech's antibody fragments demonstrate penetration into the eye with topical delivery via eye drops
25 February 2008Download -
Surface Logix reports phase 2A on SLX-4090
29 January 2008Download